Viome Life Sciences was founded in 2016 with a mission to make illness optional by predicting, reversing, and preventing chronic diseases, cancer, and aging through a deeper understanding of an individual`s biology. We provide the industry`s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need.Viome Life Sciences Health Sciences division focuses on four key initiatives including prediction, early diagnostics, prognostics, and precision therapeutics. With our state-of-the-art AI platform, we analyze data from the world`s largest and richest gene expression database in order to identify the root causes of chronic diseases and the mechanisms of action to be able to prevent and reverse these diseases.